Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

VANCOUVER, British Columbia & GRAPEVINE, Texas — Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition,” “ACI,” or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Application No. 12,551,491, entitled “Dosage Regimens for Benzgalantamine.” The issued […]


2 w.
Science
ID: 3542997356252760141


Similar News expand_more


Science
Science
Technology
Science
Science
Science
Technology
Technology
Technology
Science
Science
Science
Science
Science
Science
Economics
Science
Science
Crime
Technology
Science
Science
Technology
Science
Science
Science
Science
Science
Technology
Technology
Science
Crime
Technology
Science
Science
Technology
Science
Technology
Science
Crime
Crime
Technology
Technology
Crime
Technology
Technology
Science
Science
Economics
Add Watch Country

arrow_drop_down